Literature DB >> 25552704

Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia.

Felicitas Thol1, Michaela Scherr2, Aylin Kirchner2, Rabia Shahswar2, Karin Battmer2, Sofia Kade2, Anuhar Chaturvedi2, Christian Koenecke2, Michael Stadler2, Uwe Platzbecker3, Christian Thiede3, Thomas Schroeder4, Guido Kobbe4, Gesine Bug5, Oliver Ottmann5, Wolf-Karsten Hofmann6, Nicolaus Kröger7, Walter Fiedler8, Richard Schlenk9, Konstanze Döhner9, Hartmut Döhner9, Jürgen Krauter10, Matthias Eder2, Arnold Ganser2, Michael Heuser2.   

Abstract

Entities:  

Keywords:  AML; MDS; microRNA; mutations

Mesh：

Substances：

Year:  2014        PMID： 25552704      PMCID： PMC4380731          DOI： 10.3324/haematol.2014.120345

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.

Authors:  Xiao-Shuang Wang; Jia-Nan Gong; Jia Yu; Fang Wang; Xin-Hua Zhang; Xiao-Lin Yin; Zhen-Qing Tan; Zi-Mian Luo; Gui-Hua Yang; Chao Shen; Jun-Wu Zhang
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

2.  miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia.

Authors:  Fang Wang; Xiao-Shuang Wang; Gui-Hua Yang; Peng-Fei Zhai; Zhen Xiao; Liang-Yu Xia; Li-Rong Chen; Yu Wang; Xiao-Zhong Wang; Lai-Xi Bi; Nian Liu; Yang Yu; Da Gao; Bin-Tao Huang; Jing Wang; Dao-Bin Zhou; Jia-Nan Gong; Hua-Lu Zhao; Xiu-Hua Bi; Jia Yu; Jun-Wu Zhang
Journal:  Mol Biol Rep       Date:  2011-06-16       Impact factor: 2.316

3.  Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

Authors:  Felicitas Thol; Frederik Damm; Andrea Lüdeking; Claudia Winschel; Katharina Wagner; Michael Morgan; Haiyang Yun; Gudrun Göhring; Brigitte Schlegelberger; Dieter Hoelzer; Michael Lübbert; Lothar Kanz; Walter Fiedler; Hartmut Kirchner; Gerhard Heil; Jürgen Krauter; Arnold Ganser; Michael Heuser
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

4.  Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.

Authors:  Felicitas Thol; Sofia Kade; Carola Schlarmann; Patrick Löffeld; Michael Morgan; Jürgen Krauter; Marcin W Wlodarski; Britta Kölking; Martin Wichmann; Kerstin Görlich; Gudrun Göhring; Gesine Bug; Oliver Ottmann; Charlotte M Niemeyer; Wolf-Karsten Hofmann; Brigitte Schlegelberger; Arnold Ganser; Michael Heuser
Journal:  Blood       Date:  2012-03-02       Impact factor: 22.113

5.  Diagnostic microRNAs in myelodysplastic syndrome.

Authors:  Begum Erdogan; Crystal Facey; Julianne Qualtieri; Jason Tedesco; Elizabeth Rinker; R Benjamin Isett; John Tobias; Donald A Baldwin; James E Thompson; Martin Carroll; Annette S Kim
Journal:  Exp Hematol       Date:  2011-06-15       Impact factor: 3.084

6.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

7.  Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.

Authors:  Felicitas Thol; Robin Bollin; Marten Gehlhaar; Carolin Walter; Martin Dugas; Karl Josef Suchanek; Aylin Kirchner; Liu Huang; Anuhar Chaturvedi; Martin Wichmann; Lutz Wiehlmann; Rabia Shahswar; Frederik Damm; Gudrun Göhring; Brigitte Schlegelberger; Richard Schlenk; Konstanze Döhner; Hartmut Döhner; Jürgen Krauter; Arnold Ganser; Michael Heuser
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

8.  An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.

Authors:  M Lv; X Zhang; H Jia; D Li; B Zhang; H Zhang; M Hong; T Jiang; Q Jiang; J Lu; X Huang; B Huang
Journal:  Leukemia       Date:  2011-10-07       Impact factor: 11.528

9.  MicroRNA expression, survival, and response to interferon in liver cancer.

Authors:  Junfang Ji; Jiong Shi; Anuradha Budhu; Zhipeng Yu; Marshonna Forgues; Stephanie Roessler; Stefan Ambs; Yidong Chen; Paul S Meltzer; Carlo M Croce; Lun-Xiu Qin; Kwan Man; Chung-Mau Lo; Joyce Lee; Irene O L Ng; Jia Fan; Zhao-You Tang; Hui-Chuan Sun; Xin Wei Wang
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

10.  Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.

Authors:  Frederik Damm; Michael Heuser; Michael Morgan; Haiyang Yun; Anika Grosshennig; Gudrun Göhring; Brigitte Schlegelberger; Konstanze Döhner; Oliver Ottmann; Michael Lübbert; Wolfgang Heit; Lothar Kanz; Günter Schlimok; Aruna Raghavachar; Walter Fiedler; Hartmut Kirchner; Hartmut Döhner; Gerhard Heil; Arnold Ganser; Jürgen Krauter
Journal:  J Clin Oncol       Date:  2009-12-28       Impact factor: 44.544
View more
  7 in total

Review 1.  MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.

Authors:  Jared A Wallace; Ryan M O'Connell
Journal:  Blood       Date:  2017-07-27       Impact factor: 22.113

Review 2.  High-throughput sequencing for noninvasive disease detection in hematologic malignancies.

Authors:  Florian Scherer; David M Kurtz; Maximilian Diehn; Ash A Alizadeh
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

3.  Pan-cancer analysis of somatic mutations in miRNA genes.

Authors:  Martyna O Urbanek-Trzeciak; Paulina Galka-Marciniak; Paulina M Nawrocka; Ewelina Kowal; Sylwia Szwec; Maciej Giefing; Piotr Kozlowski
Journal:  EBioMedicine       Date:  2020-10-07       Impact factor: 8.143

4.  MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function.

Authors:  Luke B Roberts; Geraldine M Jowett; Emily Read; Tomas Zabinski; Rita Berkachy; Murray E Selkirk; Ian Jackson; Umar Niazi; Nelomi Anandagoda; Masatake Araki; Kimi Araki; Jagath Kasturiarachchi; Chela James; Tariq Enver; Rachael Nimmo; Rita Reis; Jane K Howard; Joana F Neves; Graham M Lord
Journal:  J Immunol       Date:  2021-05-21       Impact factor: 5.422

5.  Mutations in the miR-142 gene are not common in myeloproliferative neoplasms.

Authors:  Paulina Galka-Marciniak; Zuzanna Kanduła; Adrian Tire; Wladyslaw Wegorek; Kinga Gwozdz-Bak; Luiza Handschuh; Maciej Giefing; Krzysztof Lewandowski; Piotr Kozlowski
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

6.  MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis.

Authors:  Maria C Trissal; Terrence N Wong; Juo-Chin Yao; Rahul Ramaswamy; Iris Kuo; Jack Baty; Yaping Sun; Gloria Jih; Nishi Parikh; Melissa M Berrien-Elliott; Todd A Fehniger; Timothy J Ley; Ivan Maillard; Pavan R Reddy; Daniel C Link
Journal:  Cancer Res       Date:  2018-05-03       Impact factor: 13.312

7.  Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes.

Authors:  A Marshall; J Kasturiarachchi; P Datta; Y Guo; E Deltcheva; C James; J Brown; G May; N Anandagoda; I Jackson; J K Howard; E Ghazaly; S Brooks; A Khwaja; M Araki; K Araki; D Linch; G M Lord; T Enver; R Nimmo
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.